A Phase III, multi-centre, multi-national randomised control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma

UVA Tracking #
Principal Investigator
Lynn T Dengel
Contact Phone
Official Trial Title
A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
Study Description

The University of Virginia is conducting a clinical research study for adults ages 18 and over, who have melanoma. This study is being done to answer the following questions: Is a 1-centimeter margin as good as a 2-centimeter margin at reducing the risk of melanoma returning? Does having less than a 2-centimeter margin of skin removed cause fewer side effects and improve quality of life?

If you decide to take part in this study, you will have surgery with either a 1-cm margin or a 2-cm margin of healthy tissue removed. After surgery, your doctor will continue to follow your condition for 5 years. During the first 2 years you will visit the study doctor 3, 6, 12, 18, and 24 months after surgery. After that, you will visit the study doctor once a year.

Study-related procedures that are being done beyond your standard of care will be provided at no cost to you or your insurance.

Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT02385214



No Compensation